Synthetic cannabinoids further rift between marijuana and hemp industries

A recent ruling from the U.S. Drug Enforcement Administration classifying a synthetic cannabinoid as a Schedule 1 drug has furthered the ire between the licensed cannabis industry and the largely unregulated cannabinoid sector, which has grown into a multi-billion market amid the proliferation of CBD and Delta-lineage products since the passage of the 2018 Farm Bill.

Chart showing cannabinoid market breakdown

Virginia’s adult-use cannabis market stalled indefinitely

Virginia’s recreational marijuana industry is on indefinite hold.

Less than two years after the state became the first in the South to legalize adult-use marijuana for adults 21 and older, the projected start date for legal sales of Jan. 1, 2024, has been effectively scrapped.

Image of the Virginia state capitol building